5 Stocks Energizing Investors After Earnings

Omnicell Inc. (NASDAQ:OMCL) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 35% to $0.27 in the quarter versus EPS of $0.20 in the year-earlier quarter. Revenue Rose 24.3% to $93.7 million from the year-earlier quarter.

Omnicell Inc. reported adjusted EPS income of $0.27 per share. By that measure, the company beat the mean analyst estimate of $0.25. It beat the average revenue estimate of $92.42 million.

OMCL 20130803

PerkinElmer Inc. (NYSE:PKI) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased 3.77% to $0.51 in the quarter versus EPS of $0.53 in the year-earlier quarter. Revenue Rose 4.12% to $543.3 million from the year-earlier quarter.

PerkinElmer Inc. reported adjusted EPS income of $0.51 per share. By that measure, the company beat the mean analyst estimate of $0.48. It beat the average revenue estimate of $532.95 million.

PKI 20130803

Quintiles Transnational Holdings Inc (NYSE:Q) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Revenue Decreased 55.29% to $1.3 billion from the year-earlier quarter.

Quintiles Transnational Holdings Inc reported adjusted EPS income of $0.5 per share. By that measure, the company beat the mean analyst estimate of $0.46. It beat the average revenue estimate of $942.93 million.

Q 20130803

Repligen Corporation (NASDAQ:RGEN) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $0.14 in the quarter versus EPS of $0.00 in the year-earlier quarter. Revenue Rose 12.76% to $17.5 million from the year-earlier quarter.

Repligen Corporation reported adjusted EPS income of $0.14 per share. By that measure, the company beat the mean analyst estimate of $0.1. It beat the average revenue estimate of $15.97 million.

RGEN 20130803

ResMed Inc. (NYSE:RMD) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 12.73% to $0.62 in the quarter versus EPS of $0.55 in the year-earlier quarter. Revenue Rose 11.47% to $414.6 million from the year-earlier quarter.

ResMed Inc. reported adjusted EPS income of $0.62 per share. By that measure, the company beat the mean analyst estimate of $0.61. It beat the average revenue estimate of $411.06 million.

RMD 20130803

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.